<code id='5178EEB00D'></code><style id='5178EEB00D'></style>
    • <acronym id='5178EEB00D'></acronym>
      <center id='5178EEB00D'><center id='5178EEB00D'><tfoot id='5178EEB00D'></tfoot></center><abbr id='5178EEB00D'><dir id='5178EEB00D'><tfoot id='5178EEB00D'></tfoot><noframes id='5178EEB00D'>

    • <optgroup id='5178EEB00D'><strike id='5178EEB00D'><sup id='5178EEB00D'></sup></strike><code id='5178EEB00D'></code></optgroup>
        1. <b id='5178EEB00D'><label id='5178EEB00D'><select id='5178EEB00D'><dt id='5178EEB00D'><span id='5178EEB00D'></span></dt></select></label></b><u id='5178EEB00D'></u>
          <i id='5178EEB00D'><strike id='5178EEB00D'><tt id='5178EEB00D'><pre id='5178EEB00D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:358
          Robert F. Kennedy Jr.
          Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

          WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

          Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

          advertisement

          Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          AstraZeneca stays mum on Medicare drug pricing negotiations
          AstraZeneca stays mum on Medicare drug pricing negotiations

          AstraZenecaCEOPascalSoriotJacquelynMartin/APLONDON—Medicare’sfirst-everdrugpricingnegotiationsareoff

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Devoted Health’s losses in Medicare Advantage persist

          CourtesyDevotedHealthDevotedHealthhasbeenoneofthemostprominenthealthinsuranceandproviderstartupsofth